Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):1–10. https://doi.org/10.1186/s12877-017-0621-2.
Wastesson JW, Morin L, Tan ECK, Johnell K. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf. 2018;17(12):1185–96. https://doi.org/10.1080/14740338.2018.1546841.
Woodward MC. Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res. 2003;33(4):323–8. https://doi.org/10.1002/jppr2003334323.
Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of “deprescribing” with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254–68. https://doi.org/10.1111/bcp.12732.
Article PubMed PubMed Central Google Scholar
Beuscart JB, Knol W, Cullinan S, et al. International core outcome set for clinical trials of medication review in multi-morbid older patients with polypharmacy. BMC Med. 2018;16(1):21. https://doi.org/10.1186/s12916-018-1007-9.
Article PubMed PubMed Central Google Scholar
Rankin A, Cadogan CA, Ryan C, Clyne B, Smith SM, Hughes CM. Core outcome set for trials aimed at improving the appropriateness of polypharmacy in older people in primary care. J Am Geriatr Soc. 2018. https://doi.org/10.1111/jgs.15245.
Article PubMed PubMed Central Google Scholar
Aubert CE, Kerr EA, Maratt JK, Klamerus ML, Hofer TP. Outcome measures for interventions to reduce inappropriate chronic drugs: a narrative review. J Am Geriatr Soc. 2020;68(10):2390–8. https://doi.org/10.1111/jgs.16697.
Pruskowski JA, Springer S, Thorpe CT, Klein-Fedyshin M, Handler SM. Does deprescribing improve quality of life? A systematic review of the literature. Drugs Aging. 2019;36(12):1097–110. https://doi.org/10.1007/s40266-019-00717-1.
McDonald EG, Wu PE, Rashidi B, et al. The MedSafer study: electronic decision support for deprescribing in hospitalized older adults. JAMA Intern Med. 2022;182(3):265. https://doi.org/10.1001/jamainternmed.2021.7429.
Blum MR, Sallevelt BTGM, Spinewine A, et al. Optimizing therapy to prevent avoidable hospital admissions in multimorbid older adults (OPERAM): cluster randomised controlled trial. BMJ. 2021;374: n1585. https://doi.org/10.1136/bmj.n1585.
Article PubMed PubMed Central Google Scholar
Ibrahim K, Cox NJ, Stevenson JM, Lim S, Fraser SDS, Roberts HC. A systematic review of the evidence for deprescribing interventions among older people living with frailty. BMC Geriatr. 2021;21(1):258. https://doi.org/10.1186/s12877-021-02208-8.
Article PubMed PubMed Central Google Scholar
Lundby C, Pottegård A. Considerations regarding choice of primary outcome in clinical trials in deprescribing. Br J Clin Pharmacol. 2022;88(7):3032–4. https://doi.org/10.1111/bcp.14990.
James KA, Cadel L, Hitzig SL, Guilcher SJT. Patient-reported outcome measures for medication-related quality of life: a scoping review. Res Soc Admin Pharm. 2022;18(9):3501–23. https://doi.org/10.1016/j.sapharm.2022.03.003.
Jennings ELM, O’Mahony D, Gallagher PF. Medication-related quality of life (MRQoL) in ambulatory older adults with multi-morbidity and polypharmacy. Eur Geriatr Med. 2022;13(3):579–83. https://doi.org/10.1007/s41999-021-00573-6.
Bhadhuri A, Kind P, Salari P, et al. Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy. Health Qual Life Outcomes. 2020;18(1):317. https://doi.org/10.1186/s12955-020-01564-0.
Article PubMed PubMed Central Google Scholar
Holmes HM, Hayley DC, Alexander GC, Sachs GA. Reconsidering medication appropriateness for patients late in life. Arch Intern Med. 2006;166(6):605–9. https://doi.org/10.1001/archinte.166.6.605.
Hilmer SN, McLachlan AJ, Le Couteur DG. Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol. 2007;21(3):217–30. https://doi.org/10.1111/j.1472-8206.2007.00473.x.
Article CAS PubMed Google Scholar
Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18(1):143. https://doi.org/10.1186/s12874-018-0611-x.
Article PubMed PubMed Central Google Scholar
Daudt HM, van Mossel C, Scott SJ. Enhancing the scoping study methodology: a large, inter-professional team’s experience with Arksey and O’Malley’s framework. BMC Med Res Methodol. 2013;13(1):48. https://doi.org/10.1186/1471-2288-13-48.
Article PubMed PubMed Central Google Scholar
Pham MT, Rajić A, Greig JD, Sargeant JM, Papadopoulos A, McEwen SA. A scoping review of scoping reviews: advancing the approach and enhancing the consistency. Res Synth Methods. 2014;5(4):371–85. https://doi.org/10.1002/jrsm.1123.
Article PubMed PubMed Central Google Scholar
Tricco AC, Lillie E, Zarin W, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–73. https://doi.org/10.7326/M18-0850.
JBI. JBI manual for evidence synthesis. 2022. https://jbi-global-wiki.refined.site/space/MANUAL. Accessed 27 Sep 2022.
Thompson W, Xi C, Hughes C, et al. Measuring quality of life in deprescribing trials: a scoping review protocol. Open Science Framework. 2022. https://osf.io/aez6w. Accessed 10 Sep 2023.
Gnjidic D, Reeve E. Deprescribing: what do we know, and where to next? Br J Clin Pharmacol. 2021;87(3):722–4. https://doi.org/10.1111/bcp.14525.
Mohammed MA, Moles RJ, Hilmer SN, Kouladjian O’Donnel L, Chen TF. Development and validation of an instrument for measuring the burden of medicine on functioning and well-being: the Medication-Related Burden Quality of Life (MRB-QoL) tool. BMJ Open. 2018;8(1): e018880. https://doi.org/10.1136/bmjopen-2017-018880.
Article PubMed PubMed Central Google Scholar
Harzing AW. Publish or perish. 2007. https://harzing.com/resources/publish-or-perish. Accessed 1 Apr 2023.
Mokkink LB, Terwee CB, Knol DL, et al. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol. 2010;10(1):22. https://doi.org/10.1186/1471-2288-10-22.
Article PubMed PubMed Central Google Scholar
Siette J, Knaggs GT, Zurynski Y, Ratcliffe J, Dodds L, Westbrook J. Systematic review of 29 self-report instruments for assessing quality of life in older adults receiving aged care services. BMJ Open. 2021;11(11): e050892. https://doi.org/10.1136/bmjopen-2021-050892.
Article PubMed PubMed Central Google Scholar
Anderson K, Freeman C, Foster M, Scott I. GP-Led Deprescribing in community-living older Australians: an exploratory controlled trial. J Am Geriatr Soc. 2020;68(2):403–10. https://doi.org/10.1111/jgs.16273.
Ashizawa T, Mishina S, Igarashi A, Kobayashi T, Takase Y, Ikeda S. Improvement in prescriptions while maintaining overall health outcomes: a prospective observational study conducted in Japanese facilities for older people. BMC Geriatr. 2022;22(1):323. https://doi.org/10.1186/s12877-022-02872-4.
Article PubMed PubMed Central Google Scholar
Balsom C, Pittman N, King R, Kelly D. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial. Int J Clin Pharm. 2020;42(4):1153–67. https://doi.org/10.1007/s11096-020-01073-6.
Beer C, Loh P, Peng YG, Potter K, Millar A. A pilot randomized controlled trial of deprescribing. Ther Adv Drug Saf. 2011;2(2):37–43. https://doi.org/10.1177/2042098611400332.
Article PubMed PubMed Central Google Scholar
Bladh L, Ottosson E, Karlsson J, Klintberg L, Wallerstedt SM. Effects of a clinical pharmacist service on health-related quality of life and prescribing of drugs: a randomised controlled trial. BMJ Qual Saf. 2011;20(9):738–46. https://doi.org/10.1136/bmjqs.2009.039693.
Bryant LJM, Coster G, Gamble GD, McCormick RN. The General Practitioner-Pharmacist Collaboration (GPPC) study: a randomised controlled trial of clinical medication reviews in community pharmacy. Int J Pharm Pract. 2011;19(2):94–105. https://doi.org/10.1111/j.2042-7174.2010.00079.x.
Callegari E, Benth JŠ, Selbæk G, Grønnerød C, Bergh S. The effect of the NorGeP–NH on quality of life and drug prescriptions in Norwegian nursing homes: a randomized controlled trial. Pharmacy. 2022;10(1):32. https://doi.org/10.3390/pharmacy10010032.
Article PubMed PubMed Central Google Scholar
Campins L, Serra-Prat M, Gózalo I, et al. Randomized controlled trial of an intervention to improve drug appropriateness in community-dwelling polymedicated elderly people. Fam Pract. 2017;34(1):36–42. https://doi.org/10.1093/fampra/cmw073.
Cateau D, Ballabeni P, Niquille A. Effects of an interprofessional deprescribing intervention in Swiss nursing homes: the Individual Deprescribing Intervention (IDeI) randomised controlled trial. BMC Geriatr. 2021;21(1):655. https://doi.org/10.1186/s12877-021-02465-7.
留言 (0)